Evaluation of Composite Veneers Fabricated by 3D Printing and Milling Technologies
10 de agosto de 2026 atualizado por: youssef alaa
Evaluation of Composite Veneers Fabricated by 3D Printing and Milling Technologies (Randomized Controlled Clinical Trial & In-Vitro Study)
The clinical study aimed to evaluate the clinical performance, color stability, and wear of indirect composite veneers produced using 3D printing and milling technologies.
Visão geral do estudo
Status
Concluído
Descrição detalhada
A total of fifty-six anterior indirect veneers will be fabricated using 3D printing and milling technologies.
The veneers will be divided into two groups according to the technique of fabrication.
Group I: 28 veneers will be done using 3D printing technology (VarseoSmile TriniQ, Bego), and group II: 28 veneers will be done using milling technology (Cerasmart 270, GC).
Veneer restorations will be fabricated checked, and cemented, then will be evaluated using the modified FDI criteria at baseline, three months, six months, and one year.
Moreover, color stability and surface wear of the restorations will be evaluated in each follow-up session.
Tipo de estudo
Intervencional
Inscrição (Real)
14
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
-
Alexandria, Egito
- Faculty of dentistry, Alexandria university
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Não
Descrição
Inclusion Criteria:
- Healthy adult patients aged 18 to 45 years.
- Patients requiring veneer restorations due to discoloration, misalignment, tooth malformation or having irregular tooth shape that can be treated without full coverage.
- Patients meeting the criteria for Class I or Class II veneers according to the LeSage veneer classification system.
- Patients requiring veneers restorations on their bilateral maxillary anterior teeth.
- The selected teeth should be vital with absence of clinical signs and symptoms of periapical pathology.
- Patients having a normal occlusal relationship between upper and lower teeth (class I Angle classification).
- Patients capable of tolerating rubber dam applications.
- Patients willing to attend regular follow-up appointments.
Exclusion Criteria:
- Bad oral hygiene (Oral Hygiene Index Simplified >3).
- Non-vital teeth or endodontically treated teeth.
- Severe periodontal disease.
- Patients with para-functional habits (e.g., bruxism, attrition, wear facets).
- Dentin exposure more than 20% of the prepared surface for veneer.
- Prescence of smoking/vaping habits
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Dobro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Group I: 28 veneers will be done using 3D printing technology (VarseoSmile TriniQ, Bego)
|
A total of fifty-six anterior indirect veneers will be fabricated using 3D printing and milling technologies.
The veneers will be divided into two groups according to the technique of fabrication.
Group I: 28 veneers will be done using 3D printing technology (VarseoSmile TriniQ, Bego), and group II: 28 veneers will be done using milling technology (Cerasmart 270, GC).
Veneer restorations will be fabricated checked, and cemented, then will be evaluated using the modified FDI criteria at baseline, three months, six months, and one year.
Moreover, color stability and surface wear of the restorations will be evaluated in each follow-up session.
|
|
Comparador Ativo: group II: 28 veneers will be done using milling technology (Cerasmart 270, GC)
|
A total of fifty-six anterior indirect veneers will be fabricated using 3D printing and milling technologies.
The veneers will be divided into two groups according to the technique of fabrication.
Group I: 28 veneers will be done using 3D printing technology (VarseoSmile TriniQ, Bego), and group II: 28 veneers will be done using milling technology (Cerasmart 270, GC).
Veneer restorations will be fabricated checked, and cemented, then will be evaluated using the modified FDI criteria at baseline, three months, six months, and one year.
Moreover, color stability and surface wear of the restorations will be evaluated in each follow-up session.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
The functional properties of the examined veneer restorations
Prazo: 1 year
|
All veneers were assessed clinically at 1 week (baseline) and subsequently at 3, 6, and 12 months, following the FDI evaluation criteria and scoring system, which indicates: Functional properties: (F1) Fracture of material and retention.
(F2) Marginal adaptation.
(F3) Proximal contact point.
(F4) Form and contour.
(F5) Occlusion and wear.
Each evaluated property was scored according to the FDI criteria using the following clinical scores: Score 1: Clinically excellent/very good (VG), Score 2: Clinically good (CG), score 3: Clinically satisfactory (CS), score 4: Clinically unsatisfactory (CU), score 5: Clinically poor (PO).
|
1 year
|
|
The biological properties of the examined veneer restorations
Prazo: 1 year
|
All Veneers were assessed clinically at 1 week (baseline) and subsequently at 3, 6, and 12 months, following the revised FDI evaluation criteria and scoring system, which indicates: Biological properties (B1) Caries at restoration margins.
(B2) Dental hard tissue defects at the restoration margin.
(B3) Postoperative hypersensitivity and pulpal status.
Each evaluated property was scored according to the FDI criteria using the following clinical scores: Score 1: Clinically excellent/very good (VG), Score 2: Clinically good (CG), Score 3: Clinically satisfactory (CS), Score 4: Clinically unsatisfactory (CU), Score 5: Clinically poor (PO).
|
1 year
|
|
The aesthetic properties of the examined veneers
Prazo: 1 year
|
All veneers were assessed clinically at 1 week (baseline) and subsequently at 3, 6, and 12 months, following the FDI evaluation criteria and scoring system, which indicates: Aesthetic properties: (A1) Surface luster and surface texture.
(A2) Marginal staining.
(A3) Color match.
Each evaluated property was scored according to the FDI criteria using the following clinical scores: Score 1: Clinically excellent/very good (VG), Score 2: Clinically good (CG), Score 3: Clinically satisfactory (CS), Score 4: Clinically unsatisfactory (CU), Score 5: Clinically poor (PO).
|
1 year
|
|
The color stability of the examined veneers
Prazo: 1 year
|
All Veneers were assessed clinically at 1 week (baseline) and subsequently at 3, 6, 9, and 12 months using the vita easy shade spectrophotometer.
The CIEDE2000 formula will be used to measure the color change.
|
1 year
|
|
Wear resistance of the examined veneers
Prazo: 1 year
|
All Veneers were scanned clinically using an intra oral scanner at 1 week (baseline) and subsequently at 3, 6, and 12 months.
The different scans were compared to baseline scan to assess the volume loss and accordingly the wear resistant.
|
1 year
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
1 de maio de 2025
Conclusão Primária (Real)
5 de agosto de 2026
Conclusão do estudo (Real)
5 de agosto de 2026
Datas de inscrição no estudo
Enviado pela primeira vez
5 de agosto de 2026
Enviado pela primeira vez que atendeu aos critérios de CQ
5 de agosto de 2026
Primeira postagem (Real)
10 de agosto de 2026
Atualizações de registro de estudo
Última Atualização Postada (Real)
12 de agosto de 2026
Última atualização enviada que atendeu aos critérios de controle de qualidade
10 de agosto de 2026
Última verificação
1 de agosto de 2026
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- 9262109
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .